Nadh and nadph as drugs for treating alzheimer's disease

Details Nadh and nadph as drugs for treating alzheimer's disease Nadh and nadph as drugs for treating alzheimer's disease

A - Human Necessities

61

K

A61K 31/70 (2006.01) A61K 31/455 (2006.01) A61K 31/465 (2006.01) A61K 31/7084 (2006.01) A61K 31/7105 (2006.01) A61P 25/28 (2006.01) C07H 19/207 (2006.01) C07H 21/02 (2006.01)

Patent

CA 2105912

Use of the reduced form of nicotinamide adenine dinucleotide (NADH), the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH), or a physiologically compatible salt thereof for the treatment of Alzheimer's disease is disclosed. Also disclosed is a composition for the treatment of Alzheimer's disease. The composition comprises NADH, NADPH or a physiologically compatible salt thereof and a pharmaceutically acceptable carrier.

Affiliated with

Also associated with

Rating

Nadh and nadph as drugs for treating alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nadh and nadph as drugs for treating alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nadh and nadph as drugs for treating alzheimer's disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1746683